This study looks at how many healthcare workers at CHSD hospital developed antibodies against COVID-19 after the second and third waves of the pandemic and after receiving a vaccine. It aims to better understand who might still be at risk of infection, how long immunity lasts after getting COVID or the vaccine, and how reliable previous antibody tests were. Blood samples will be collected from volunteer hospital staff during a one-month period to measure their antibody levels and compare them to earlier results.
Study Type
OBSERVATIONAL
Enrollment
447
France
Saint-Denis, France, France
SARS-CoV-2 antibody prevalence (seroprevalence) among healthcare workers at CHSD
Time frame: 1 month (during the serological testing period)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.